Dynamic Technology Lab’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,159
Closed -$79K 1288
2024
Q4
$79K Buy
+10,159
New +$95.4K 0.01% 829
2024
Q3
Sell
-48,954
Closed -$573K 1299
2024
Q2
$573K Buy
48,954
+32,002
+189% +$498K 0.06% 462
2024
Q1
$357K Buy
+16,952
New +$302K 0.04% 718
2023
Q2
Sell
-29,239
Closed -$553K 1362
2023
Q1
$553K Buy
29,239
+18,989
+185% +$420K 0.05% 585
2022
Q4
$232K Sell
10,250
-7,870
-43% -$178K 0.02% 868
2022
Q3
$479K Buy
+18,120
New +$538K 0.05% 646
2019
Q2
Sell
-11,223
Closed -$643K 1237
2019
Q1
$643K Buy
+11,223
New +$556K 0.11% 316
2018
Q1
Sell
-11,711
Closed -$390K 1310
2017
Q4
$390K Sell
11,711
-2,334
-17% -$70.3K 0.07% 567
2017
Q3
$463K Buy
+14,045
New +$316K 0.08% 477

Other funds holding RGNX

Dynamic Technology Lab's RGNX Position: Q1 2025 in Review

Dynamic Technology Lab sold out of Regenxbio (RGNX) in Q1 2025, closing a stake of 10,159 shares — an estimated $79K sold.

Dynamic Technology Lab first reported a position in RGNX in Q3 2017 and held it in 9 quarters. The position peaked at $643K in Q1 2019. 164 funds tracked by Wall St. Rank hold RGNX as of Q1 2025.

  • Dynamic Technology Lab reported no remaining Regenxbio position as of Q1 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 10,159 Regenxbio shares in Q1 2025, an estimated $79K.
  • Dynamic Technology Lab first reported a position in Regenxbio in Q3 2017 and held it in 9 quarters.
  • Dynamic Technology Lab's Regenxbio position peaked at $643K in Q1 2019.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q1 2025.

Based on Dynamic Technology Lab's 13F filing for Q1 2025, filed 16 May 2025.